PinnyPeptide

Glow Blend (BPC-157 + TB-500 + GHK-Cu) vs Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Glow Blend (BPC-157 + TB-500 + GHK-Cu)

Peptide Blends

Wolverine's healing duo plus GHK-Cu — soft-tissue recovery with a cosmetic kicker for skin, hair, and scars.

Peptide B

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)

Peptide Blends

Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial.

Typical vial

70 mg

Typical dose

250 + 2000 + 1000 (BPC + TB + GHK) mcg

Half-life

BPC-157 ~4 h; TB-500 ~6-8 h; GHK-Cu ~minutes systemically (longer in tissue)

FDA status

No component FDA approved for human use. FDA issued a warnin…

Typical vial

80 mg

Typical dose

500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg

Half-life

KPV ~minutes; BPC-157 ~4 h; TB-500 ~6-8 h; GHK-Cu ~minutes systemically

FDA status

No component FDA approved for human use. FDA issued a warnin…

Glow Blend (BPC-157 + TB-500 + GHK-Cu) effects

  • Soft-tissue healing and tendon recovery (BPC + TB contribution)
  • Stimulates collagen synthesis and skin elasticity (GHK-Cu contribution)
  • Reduces scar formation and supports scar remodelling
  • Promotes hair-follicle health and may support regrowth
  • Angiogenesis and improved blood flow to repair sites
  • Modulates inflammation across all three pathways

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) effects

  • Broad anti-inflammatory action across NF-κB, nitric oxide, and copper-modulation pathways
  • Soft-tissue healing and tendon recovery (BPC + TB contribution)
  • Stimulates collagen synthesis and skin elasticity (GHK-Cu contribution)
  • Anti-inflammatory action in the gut and inflamed skin (KPV contribution)
  • Modulates the gut-skin axis (anecdotal, component-derived)
  • Reduces scar formation and supports remodelling
  • Promotes angiogenesis and improved blood flow to repair sites

Glow Blend (BPC-157 + TB-500 + GHK-Cu) side effects

  • Injection site irritation, occasionally with mild bluish tint from copper
  • Temporary lightheadedness
  • Mild lethargy in first 1-2 weeks
  • Headache
  • Nausea at upper dosing range
  • Rare metallic taste reported with GHK-Cu

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) side effects

  • Injection site irritation (occasionally with mild bluish tint from copper)
  • Temporary lightheadedness
  • Mild lethargy in first 1-2 weeks
  • Headache
  • Nausea at upper dosing range
  • Possible flushing from MSH-pathway activity (KPV)

Glow Blend (BPC-157 + TB-500 + GHK-Cu) dosing ranges

Recovery + cosmetic loading

250 mcg BPC + 2 mg TB-500 + 1-2 mg GHK-Cu · BPC daily, TB-500 twice weekly, GHK-Cu daily · 6-8 weeks

Scar remodelling protocol

250 mcg BPC + 2 mg TB-500 + 2 mg GHK-Cu · BPC daily, TB-500 weekly, GHK-Cu daily (site-local) · 8-12 weeks

Maintenance stack

250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · BPC 3-4x weekly, others weekly · Ongoing cycles

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) dosing ranges

Inflammation + recovery loading

500 mcg KPV + 250 mcg BPC + 2 mg TB-500 + 1-2 mg GHK-Cu · KPV + BPC + GHK daily, TB-500 twice weekly · 6-8 weeks

Gut-skin axis protocol

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · Daily, with TB-500 weekly · 8-12 weeks

Maintenance

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · KPV + BPC 3-4x weekly, others weekly · Ongoing cycles

Glow Blend (BPC-157 + TB-500 + GHK-Cu) vs Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) — common questions

What is the difference between Glow Blend (BPC-157 + TB-500 + GHK-Cu) and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

Glow Blend (BPC-157 + TB-500 + GHK-Cu): Wolverine's healing duo plus GHK-Cu — soft-tissue recovery with a cosmetic kicker for skin, hair, and scars. Typical dose 250 + 2000 + 1000 (BPC + TB + GHK) mcg. Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial. Typical dose 500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg. Both fall under the Peptide Blends category.

Can you stack Glow Blend (BPC-157 + TB-500 + GHK-Cu) and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

Stacking Glow Blend (BPC-157 + TB-500 + GHK-Cu) with Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Glow Blend (BPC-157 + TB-500 + GHK-Cu) or Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

Glow Blend (BPC-157 + TB-500 + GHK-Cu) is typically dosed: BPC daily, TB-500 twice weekly, GHK-Cu daily for Recovery + cosmetic loading; BPC daily, TB-500 weekly, GHK-Cu daily (site-local) for Scar remodelling protocol; BPC 3-4x weekly, others weekly for Maintenance stack. Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) is typically dosed: KPV + BPC + GHK daily, TB-500 twice weekly for Inflammation + recovery loading; Daily, with TB-500 weekly for Gut-skin axis protocol; KPV + BPC 3-4x weekly, others weekly for Maintenance.

Are Glow Blend (BPC-157 + TB-500 + GHK-Cu) and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) FDA approved?

Glow Blend (BPC-157 + TB-500 + GHK-Cu): No component FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products. Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): No component FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free